Vir Biotechnology, Inc.
US ˙ NasdaqGS ˙ US92764N1028

Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di George A Scangos. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che George A Scangos ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
US:A / Agilent Technologies, Inc. Director 20.493
US:VIR / Vir Biotechnology, Inc. Director 698.239
US:EXEL / Exelixis, Inc. Director 714.717
US:BIIB / Biogen Inc. Chief Executive Officer, Director 54.779
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da George A Scangos. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Acquisti di insider VIR / Vir Biotechnology, Inc. - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in VIR / Vir Biotechnology, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

VIR / Vir Biotechnology, Inc. Insider Trades
Vendite di insider VIR / Vir Biotechnology, Inc. - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in VIR / Vir Biotechnology, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
2025-02-24 VIR SCANGOS GEORGE A 10.056 9,4534 10.056 9,4534 95.063 168 4.2800 -52.023 -54,73
2025-02-18 VIR SCANGOS GEORGE A 10.964 9,8117 10.964 9,8117 107.575
2024-02-22 VIR SCANGOS GEORGE A 10.028 10,0456 10.028 10,0456 100.737
2024-02-16 VIR SCANGOS GEORGE A 10.878 10,2396 10.878 10,2396 111.386
2023-02-23 VIR SCANGOS GEORGE A 12.631 25,9730 12.631 25,9730 328.065
2023-02-17 VIR SCANGOS GEORGE A 9.894 25,2880 9.894 25,2880 250.199
2022-02-17 VIR SCANGOS GEORGE A 10.024 31,9308 10.024 31,9308 320.074

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

VIR / Vir Biotechnology, Inc. Insider Trades
Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da George A Scangos come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2025-03-18 2025-03-14 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
A - Award 1.819 20.493 9,74 121,18 220.426 2.483.351
2025-02-25 2025-02-24 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale -10.056 698.239 -1,42 9,45 -95.063 6.600.733
2025-02-19 2025-02-18 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale -10.964 708.295 -1,52 9,81 -107.575 6.949.578
2024-10-24 2024-10-23 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -598.270 1.151.730 -34,19
2024-10-24 2024-10-23 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -598.270 1.151.730 -34,19
2024-10-24 2024-10-23 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other 598.270 598.270
2024-10-24 2024-10-23 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other 598.270 598.270
2024-06-03 2024-05-30 4 VIR Vir Biotechnology, Inc.
Common Stock
A - Award 8.000 120.989 7,08
2024-05-31 2024-05-29 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
G - Gift 3.443 17.893 23,83 145,48 500.888 2.603.074
2024-05-31 2024-05-29 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
G - Gift -3.443 18.578 -15,64 145,48 -500.888 2.702.709
2024-03-19 2024-03-15 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
A - Award 1.678 21.989 8,26 147,48 247.471 3.242.990
2024-02-26 2024-02-26 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale X -17.722 112.989 -13,56 11,65 -206.522 1.316.706
2024-02-26 2024-02-22 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale -10.028 130.711 -7,13 10,05 -100.737 1.313.070
2024-02-20 2024-02-20 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale X -16.872 140.739 -10,70 10,22 -172.385 1.437.959
2024-02-20 2024-02-16 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale -10.878 157.611 -6,46 10,24 -111.386 1.613.874
2023-10-18 2023-10-17 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other 1.750.000 1.750.000
2023-10-18 2023-10-17 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other 1.750.000 1.750.000
2023-10-18 2023-10-17 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -1.750.000 0 -100,00
2023-10-18 2023-10-17 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -1.750.000 0 -100,00
2023-09-18 2023-09-15 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -827.151 0 -100,00
2023-09-18 2023-09-15 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -827.151 0 -100,00
2023-09-18 2023-09-15 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -111.644 0 -100,00
2023-09-18 2023-09-15 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -111.644 0 -100,00
2023-09-18 2023-09-15 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other 1.750.000 1.750.000
2023-09-18 2023-09-15 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other 1.750.000 1.750.000
2023-09-18 2023-09-15 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -3.500.000 33.629 -99,05
2023-03-20 2023-03-16 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
A - Award 1.658 20.185 8,95 136,82 226.848 2.761.700
2023-02-24 2023-02-24 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale X -10.880 168.489 -6,07 23,56 -256.300 3.969.095
2023-02-24 2023-02-24 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale X -4.239 179.369 -2,31 22,74 -96.382 4.078.313
2023-02-24 2023-02-23 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale -12.631 183.608 -6,44 25,97 -328.065 4.768.851
2023-02-21 2023-02-21 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale X -6.474 196.239 -3,19 28,80 -186.451 5.651.683
2023-02-21 2023-02-21 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale X -11.382 202.713 -5,32 28,02 -318.867 5.679.005
2023-02-21 2023-02-17 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale -9.894 214.095 -4,42 25,29 -250.199 5.414.034
2023-02-21 2023-01-18 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other 64.930 179.930 56,46
2023-02-21 2023-01-18 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -64.930 3.533.629 -1,80
2023-02-21 2022-12-21 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other 49.984 111.644 81,06
2023-02-21 2022-12-21 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other 49.984 111.644 81,06
2023-02-21 2022-12-21 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -49.984 827.151 -5,70
2023-02-21 2022-12-21 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -49.984 827.151 -5,70
2022-04-06 2022-03-10 4 VIR Vir Biotechnology, Inc.
Stock Option (Right to Buy)
A - Award 222.000 222.000
2022-04-06 2022-03-10 4 VIR Vir Biotechnology, Inc.
Common Stock
A - Award 111.000 223.989 98,24
2022-03-21 2022-03-17 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
A - Award 1.785 18.420 10,73 136,82 244.224 2.520.206
2022-02-22 2022-02-18 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale X -17.726 112.989 -13,56 30,65 -543.304 3.463.124
2022-02-22 2022-02-17 4 VIR Vir Biotechnology, Inc.
Common Stock
S - Sale -10.024 130.715 -7,12 31,93 -320.074 4.173.835
2022-02-14 2021-09-07 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift 29.739 140.739 26,79
2022-02-14 2021-09-07 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift 877.135 877.135
2022-02-14 2021-09-07 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift 877.135 877.135
2022-02-14 2021-09-07 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift 61.660 61.660
2022-02-14 2021-09-07 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift 61.660 61.660
2022-02-14 2021-09-07 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift -1.907.329 0 -100,00
2022-02-14 2021-04-01 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift 3.598.559 3.598.559
2022-02-14 2021-04-01 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift -3.598.559 111.000 -97,01
2022-02-14 2021-02-16 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift -900.000 3.709.559 -19,52
2021-03-22 2021-03-18 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
A - Award 986 16.544 6,34 121,59 119.891 2.011.599
2021-03-22 2021-03-18 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
A - Award 1.850 15.558 13,50 121,59 224.947 1.891.709
2021-02-18 2021-02-16 4 VIR Vir Biotechnology, Inc.
Stock Option (Right to Buy)
A - Award 222.000 222.000
2021-02-18 2021-02-16 4 VIR Vir Biotechnology, Inc.
Common Stock
A - Award 111.000 4.609.559 2,47
2021-02-12 2020-12-28 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift -100.000 4.498.559 -2,17
2021-02-12 2020-12-02 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift 115.000 115.000
2021-02-12 2020-12-02 5 VIR Vir Biotechnology, Inc.
Common Stock
G - Gift -115.000 4.598.559 -2,44
2020-08-05 2020-08-03 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
A - Award 177 28.112 0,63 93,91 16.622 2.640.013
2020-05-20 2020-05-18 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -75.000 714.717 -9,50 25,96 -1.947.000 18.554.053
2020-05-15 2020-05-15 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -21.686 0 -100,00
2020-05-15 2020-05-15 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -30.000 0 -100,00
2020-05-15 2020-05-15 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 21.686 789.717 2,82 5,82 126.213 4.596.153
2020-05-15 2020-05-15 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 30.000 768.031 4,06 4,58 137.400 3.517.582
2020-04-24 2020-04-24 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -15.000 738.031 -1,99 26,24 -393.600 19.365.933
2020-04-24 2020-04-23 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -55.700 753.031 -6,89 26,23 -1.461.011 19.752.003
2020-04-24 2020-04-23 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -44.300 808.731 -5,19 25,68 -1.137.624 20.768.212
2020-04-22 2020-04-22 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -4.200 853.031 -0,49 25,05 -105.210 21.368.427
2020-04-22 2020-04-21 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -5.800 857.231 -0,67 25,04 -145.232 21.465.064
2020-04-22 2020-04-20 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -5.900 863.031 -0,68 24,70 -145.730 21.316.866
2020-04-22 2020-04-20 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -25.600 868.931 -2,86 24,07 -616.192 20.915.169
2020-04-22 2020-04-20 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -18.500 894.531 -2,03 23,39 -432.715 20.923.080
2020-04-21 2020-04-17 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
A - Award 1.027 27.887 3,82 73,01 74.980 2.036.035
2020-04-21 2020-04-17 4 A AGILENT TECHNOLOGIES, INC.
Common Stock
A - Award 3.081 26.860 12,96 73,01 224.941 1.961.055
2020-04-17 2020-04-15 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -25.000 913.031 -2,67 18,31 -457.750 16.717.598
2020-04-16 2020-04-14 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other 236.806 4.713.559 5,29 29,56 6.999.985 139.332.804
2020-04-16 2020-04-14 4 VIR Vir Biotechnology, Inc.
Common Stock
J - Other -236.806 1.907.329 -11,04 29,56 -6.999.985 56.380.645
2020-04-09 2020-04-08 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -7.065 938.031 -0,75 18,35 -129.643 17.212.869
2020-04-09 2020-04-07 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -16.435 945.096 -1,71 18,25 -299.939 17.248.002
2020-04-02 2020-03-31 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -1.500 961.531 -0,16 18,06 -27.090 17.365.250
2020-02-21 2020-02-18 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -50.000 963.031 -4,94 20,73 -1.036.500 19.963.633
2020-02-12 2020-02-12 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -21.000 1.013.031 -2,03 20,02 -420.420 20.280.881
2020-02-12 2020-02-11 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -4.000 1.034.031 -0,39 20,14 -80.560 20.825.384
2020-01-24 2020-01-22 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -25.000 1.038.031 -2,35 19,75 -493.750 20.501.112
2020-01-17 2020-01-15 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -25.000 1.063.031 -2,30 20,39 -509.750 21.675.202
2019-12-27 2019-12-27 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -25.000 1.090.531 -2,24 18,25 -456.250 19.902.191
2019-12-27 2019-12-12 4 EXEL EXELIXIS, INC.
Common Stock
G - Gift -12.500 1.115.531 -1,11
2019-10-10 3 VIR Vir Biotechnology, Inc.
Common Stock
11.019.554
2019-10-10 3 VIR Vir Biotechnology, Inc.
Common Stock
8.843.110
2019-10-10 3 VIR Vir Biotechnology, Inc.
Common Stock
11.019.554
2019-10-10 3 VIR Vir Biotechnology, Inc.
Common Stock
8.843.110
2019-10-10 3 VIR Vir Biotechnology, Inc.
Common Stock
11.019.554
2019-10-10 3 VIR Vir Biotechnology, Inc.
Common Stock
8.843.110
2019-08-02 2019-08-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -6.050 1.128.031 -0,53 21,23 -128.442 23.948.098
2019-08-02 2019-08-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -33.950 1.134.081 -2,91 20,48 -695.296 23.225.979
2019-07-03 2019-07-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -40.000 1.168.031 -3,31 21,58 -863.200 25.206.109
2019-06-05 2019-06-04 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -15.000 1.208.031 -1,23 20,00 -300.000 24.160.620
2019-06-05 2019-06-03 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -25.000 1.223.031 -2,00 19,61 -490.250 23.983.638
2019-05-24 2019-05-23 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 42.641 42.641
2019-05-22 2019-05-21 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -15.000 0 -100,00
2019-05-22 2019-05-21 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 15.000 1.248.031 1,22 4,57 68.550 5.703.502
2019-05-03 2019-05-02 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -15.000 1.233.031 -1,20 20,00 -300.000 24.660.620
2019-05-03 2019-05-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -25.000 1.248.031 -1,96 19,75 -493.750 24.648.612
2019-04-03 2019-04-03 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -5.000 1.273.031 -0,39 25,03 -125.150 31.863.966
2019-04-03 2019-04-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -40.000 1.278.031 -3,03 24,02 -960.800 30.698.305
2019-03-22 2019-03-21 4 A AGILENT TECHNOLOGIES INC
Common Stock
A - Award 1.255 23.699 5,59 82,00 102.899 1.943.309
2019-03-22 2019-03-21 4 A AGILENT TECHNOLOGIES INC
Common Stock
A - Award 2.823 22.444 14,39 82,00 231.486 1.840.409
2019-03-15 2019-03-14 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -5.000 1.318.031 -0,38 25,00 -125.000 32.950.775
2019-03-01 2019-03-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -40.000 1.323.031 -2,93 22,66 -906.400 29.979.882
2019-02-01 2019-02-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -40.000 1.363.031 -2,85 23,53 -941.200 32.072.119
2019-01-04 2019-01-03 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -96 1.403.031 -0,01 20,00 -1.920 28.060.620
2019-01-04 2019-01-02 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -39.904 1.403.127 -2,77 19,64 -783.715 27.557.414
2019-01-04 2018-12-15 4 EXEL EXELIXIS, INC.
Common Stock
G - Gift -9.300 1.443.031 -0,64
2019-01-04 2018-12-15 4 EXEL EXELIXIS, INC.
Common Stock
G - Gift -4.650 1.452.331 -0,32
2018-12-03 2018-12-03 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -40.000 1.456.981 -2,67 21,16 -846.400 30.829.718
2018-12-03 2018-11-30 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -8.500 1.496.981 -0,56 20,00 -170.000 29.939.620
2018-12-03 2018-11-29 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -6.500 1.505.481 -0,43 20,00 -130.000 30.109.620
2018-11-02 2018-11-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -10.000 1.511.981 -0,66 14,14 -141.400 21.379.411
2018-11-02 2018-11-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -15.000 1.521.981 -0,98 15,00 -225.000 22.829.715
2018-10-03 2018-10-01 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale X -25.000 1.536.981 -1,60 17,86 -446.500 27.450.481
2018-09-26 2018-09-24 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale -25.000 1.561.981 -1,58 16,85 -421.250 26.319.380
2018-08-10 2018-08-10 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -33.333 0 -100,00
2018-08-10 2018-08-10 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -75.000 0 -100,00
2018-08-10 2018-08-10 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 33.333 1.586.981 2,15 4,42 147.332 7.014.456
2018-08-10 2018-08-10 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 75.000 1.553.648 5,07 5,04 378.000 7.830.386
2018-05-24 2018-05-24 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 31.167 31.167
2018-05-16 2018-05-15 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -15.000 0 -100,00
2018-05-16 2018-05-15 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 15.000 1.478.648 1,02 11,66 174.900 17.241.036
2018-03-23 2018-03-22 4 A AGILENT TECHNOLOGIES INC
Common Stock
A - Award 1.438 19.574 7,93 67,47 97.026 1.320.648
2018-03-23 2018-03-22 4 A AGILENT TECHNOLOGIES INC
Common Stock
A - Award 2.876 18.136 18,85 67,47 194.044 1.223.622
2017-05-26 2017-05-25 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 23.491 23.491
2017-03-17 2017-03-16 4 A AGILENT TECHNOLOGIES INC
Common Stock
A - Award 3.866 15.253 33,95 53,05 205.091 809.167
2016-12-07 2016-12-07 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -356 0 -100,00
2016-12-07 2016-12-07 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale -176 1.463.648 -0,01 17,90 -3.150 26.199.299
2016-12-07 2016-12-07 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 356 1.463.824 0,02 8,99 3.200 13.159.778
2016-12-07 2016-12-05 4 EXEL EXELIXIS, INC.
Option (right to buy)
M - Exercise -357.976 356 -99,90
2016-12-07 2016-12-05 4 EXEL EXELIXIS, INC.
Common Stock
S - Sale -204.718 1.463.468 -12,27 17,81 -3.646.028 26.064.365
2016-12-07 2016-12-05 4 EXEL EXELIXIS, INC.
Common Stock
M - Exercise 357.976 1.668.186 27,32 8,99 3.218.204 14.996.992
2016-07-22 2016-07-21 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -157 54.779 -0,29 280,00 -43.960 15.338.120
2016-06-06 2016-06-03 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -842 54.936 -1,51 290,00 -244.180 15.931.440
2016-06-02 2016-06-01 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -487 55.778 -0,87 287,97 -140.241 16.062.391
2016-06-02 2016-05-31 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -3.368 56.265 -5,65 290,00 -976.720 16.316.850
2016-05-27 2016-05-25 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -157 59.633 -0,26 280,00 -43.960 16.697.240
2016-05-26 2016-05-26 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 40.000 40.000
2016-05-04 2016-05-02 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -487 59.790 -0,81 274,74 -133.798 16.426.705
2016-04-07 2016-04-06 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -157 60.277 -0,26 280,00 -43.960 16.877.560
2016-04-05 2016-04-01 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -487 60.434 -0,80 258,83 -126.050 15.642.132
2016-03-18 2016-03-17 4 A AGILENT TECHNOLOGIES INC
Common Stock
A - Award 4.704 11.378 70,48 39,29 184.820 447.058
2016-03-03 2016-03-01 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -487 60.921 -0,79 261,37 -127.287 15.922.922
2016-03-03 2015-02-12 4/A BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -9.189 18.380 -33,33
2016-03-03 2015-02-12 4/A BIIB BIOGEN INC.
Common Stock
M - Exercise 9.189 43.466 26,81
2016-02-25 2016-02-23 4 BIIB BIOGEN INC.
Restricted Stock Unit
J - Other -5.884 17.702 -24,95
2016-02-25 2016-02-23 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -2.964 23.586 -11,16
2016-02-25 2016-02-23 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -1.395 61.417 -2,22 258,99 -361.291 15.906.389
2016-02-25 2016-02-23 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 2.964 62.812 4,95
2016-02-24 2016-02-22 4 BIIB BIOGEN INC.
Restricted Stock Unit
A - Award 40.460 40.460
2016-02-19 2016-02-17 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -487 59.848 -0,81 256,16 -124.750 15.330.664
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Restricted Stock Unit
J - Other -5.982 10.502 -36,29
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -9.189 9.182 -50,02
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -4.512 16.484 -21,49
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -5.359 60.335 -8,16 247,22 -1.324.852 14.916.019
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Common Stock
A - Award 11.390 65.694 20,97
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -4.324 54.304 -7,38 247,22 -1.068.979 13.425.035
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 9.189 58.628 18,59
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -2.132 49.439 -4,13 247,22 -527.073 12.222.310
2016-02-17 2016-02-12 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 4.512 51.571 9,59
2016-02-10 2016-02-09 4 BIIB BIOGEN INC.
Restricted Stock Unit
M - Exercise -11.274 0 -100,00
2016-02-10 2016-02-09 4 BIIB BIOGEN INC.
Common Stock
F - Taxes -5.305 47.059 -10,13 249,99 -1.326.197 11.764.279
2016-02-10 2016-02-09 4 BIIB BIOGEN INC.
Common Stock
M - Exercise 11.274 52.364 27,44
2016-01-05 2016-01-04 4 EXEL EXELIXIS, INC.
Common Stock
A - Award 6.383 1.310.210 0,49
2015-06-02 2015-06-01 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -1.362 41.090 -3,21 398,87 -543.261 16.389.568
2015-05-28 2015-05-28 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 40.000 40.000
2015-05-05 2015-05-01 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -1.362 42.452 -3,11 377,52 -514.182 16.026.479
2015-04-02 2015-04-01 4 BIIB BIOGEN INC.
Common Stock
S - Sale X -1.362 43.814 -3,01 423,20 -576.398 18.542.085
2015-03-20 2015-03-19 4 A AGILENT TECHNOLOGIES INC
Common Stock
A - Award 4.311 6.666 183,06 42,21 181.967 281.373
2015-03-16 2015-03-13 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -537 45.176 -1,17 412,69 -221.613 18.643.593
2015-03-03 2015-03-02 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -825 45.713 -1,77 410,67 -338.803 18.772.958
2015-02-25 2015-02-23 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
A - Award 26.550 26.550
2015-02-20 2015-02-19 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -537 46.538 -1,14 401,04 -215.358 18.663.600
2015-02-18 2015-02-17 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -825 47.075 -1,72 389,11 -321.016 18.317.353
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
J - Other -4.093 20.996 -16,31
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -6.401 25.089 -20,33
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -9.198 18.371 -33,36
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -4.781 47.900 -9,08 392,11 -1.874.678 18.782.069
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
A - Award 10.149 52.681 23,86
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -3.015 42.532 -6,62 392,11 -1.182.212 16.677.223
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 6.401 45.547 16,35
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -4.329 39.146 -9,96 392,11 -1.697.444 15.349.538
2015-02-17 2015-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 9.198 43.475 26,83
2015-02-11 2015-02-10 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -18.833 0 -100,00
2015-02-11 2015-02-10 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -8.871 34.277 -20,56 395,13 -3.505.198 13.543.871
2015-02-11 2015-02-10 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 18.833 43.148 77,45
2015-02-11 2015-02-09 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -11.270 11.274 -49,99
2015-02-11 2015-02-09 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -4.940 24.315 -16,89 396,88 -1.960.587 9.650.137
2015-02-11 2015-02-09 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 11.270 29.255 62,66
2014-11-04 2014-11-03 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.128 17.985 -5,90 320,78 -361.840 5.769.228
2014-10-16 2014-10-14 4 EXEL EXELIXIS, INC.
Common Stock
A - Award 29.412 1.303.827 2,31
2014-10-02 2014-10-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.127 19.113 -5,57 330,97 -373.003 6.325.830
2014-09-18 2014-09-17 4 A AGILENT TECHNOLOGIES INC
Common Stock
A - Award 784 2.353 49,97 58,89 46.170 138.568
2014-09-18 2014-09-17 4 A AGILENT TECHNOLOGIES INC
Common Stock
A - Award 1.569 1.569 58,89 92.398 92.398
2014-09-04 2014-09-02 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.128 20.240 -5,28 345,47 -389.690 6.992.313
2014-08-04 2014-08-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.128 21.368 -5,01 332,93 -375.545 7.114.048
2014-07-18 2014-07-16 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -12.316 22.496 -35,38 312,37 -3.847.149 7.027.076
2014-07-17 2014-07-15 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -21.339 0 -100,00
2014-07-17 2014-07-15 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -10.062 34.812 -22,42 312,00 -3.139.344 10.861.344
2014-07-17 2014-07-15 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 21.339 44.874 90,67
2014-06-03 2014-06-02 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -484 23.535 -2,02 318,93 -154.362 7.506.018
2014-05-30 2014-05-29 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 40.000 40.000
2014-05-02 2014-05-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -995 24.019 -3,98 285,49 -284.063 6.857.184
2014-05-02 2014-05-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -642 25.014 -2,50 285,43 -183.246 7.139.746
2014-05-02 2014-05-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -486 25.656 -1,86 285,87 -138.933 7.334.281
2014-04-02 2014-04-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -2.123 26.142 -7,51 308,42 -654.776 8.062.716
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -100 28.265 -0,35 338,05 -33.805 9.554.983
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -2.065 28.365 -6,79 337,25 -696.421 9.566.096
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -3.001 30.430 -8,98 336,49 -1.009.806 10.239.391
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -3.985 33.431 -10,65 335,25 -1.335.971 11.207.743
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -5.673 37.416 -13,17 334,54 -1.897.845 12.517.149
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -2.300 43.089 -5,07 333,61 -767.303 14.374.921
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -3.280 45.389 -6,74 332,40 -1.090.272 15.087.304
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -2.420 48.669 -4,74 331,55 -802.351 16.136.207
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -900 51.089 -1,73 330,65 -297.585 16.892.578
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -500 51.989 -0,95 329,06 -164.530 17.107.500
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.200 52.489 -2,24 328,38 -394.056 17.236.338
2014-03-12 2014-03-10 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -700 53.689 -1,29 327,76 -229.432 17.597.107
2014-03-04 2014-03-03 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -486 54.389 -0,89 335,79 -163.194 18.263.282
2014-03-04 2014-03-03 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.493 54.875 -2,65 335,79 -501.334 18.426.476
2014-03-04 2014-03-03 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -963 56.368 -1,68 335,79 -323.366 18.927.811
2014-02-14 2014-02-13 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -486 57.331 -0,84 316,81 -153.970 18.163.034
2014-02-14 2014-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
A - Award 31.490 31.490
2014-02-14 2014-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -9.189 27.569 -25,00
2014-02-14 2014-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -4.333 57.817 -6,97 323,04 -1.399.732 18.677.204
2014-02-14 2014-02-12 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 9.189 62.150 17,35
2014-02-12 2014-02-11 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.493 52.961 -2,74 314,31 -469.265 16.646.172
2014-02-12 2014-02-11 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -963 54.454 -1,74 314,31 -302.681 17.115.437
2014-02-11 2014-02-10 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -18.833 18.833 -50,00
2014-02-11 2014-02-10 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -8.880 55.417 -13,81 315,54 -2.801.995 17.486.280
2014-02-11 2014-02-10 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 18.833 64.297 41,42
2014-02-11 2014-02-09 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -11.270 22.544 -33,33
2014-02-11 2014-02-09 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -4.850 45.464 -9,64 315,54 -1.530.369 14.345.711
2014-02-11 2014-02-09 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 11.270 50.314 28,86
2013-12-09 2013-12-06 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 21.686 21.686
2013-11-05 2013-11-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.112 39.044 -2,77 245,57 -273.074 9.588.035
2013-11-05 2013-11-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.127 40.156 -2,73 245,57 -276.757 9.861.109
2013-10-02 2013-10-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.112 41.283 -2,62 242,85 -270.049 10.025.577
2013-10-02 2013-10-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.127 42.395 -2,59 242,85 -273.692 10.295.626
2013-09-04 2013-09-03 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -200 43.522 -0,46 216,31 -43.262 9.414.244
2013-09-04 2013-09-03 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -912 43.722 -2,04 213,30 -194.530 9.325.903
2013-09-04 2013-09-03 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -300 44.634 -0,67 216,26 -64.876 9.652.326
2013-09-04 2013-09-03 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -600 44.934 -1,32 214,74 -128.843 9.649.037
2013-09-04 2013-09-03 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -227 45.534 -0,50 213,80 -48.531 9.734.942
2013-08-02 2013-08-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -2.239 45.761 -4,66 218,82 -489.938 10.013.422
2013-07-18 2013-07-16 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -2.239 48.000 -4,46 223,94 -501.402 10.749.120
2013-07-16 2013-07-15 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -21.339 21.339 -50,00
2013-07-16 2013-07-15 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -9.938 50.239 -16,51 224,33 -2.229.392 11.270.115
2013-07-16 2013-07-15 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -10.073 60.177 -14,34 224,33 -2.259.676 13.499.506
2013-07-16 2013-07-15 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 21.339 70.250 43,63
2013-06-04 2013-06-03 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.598 48.911 -3,16 234,16 -374.188 11.453.000
2013-05-24 2013-05-23 4 EXEL EXELIXIS, INC.
Option (right to buy)
A - Award 30.000 30.000
2013-05-03 2013-05-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.598 50.509 -3,07 215,39 -344.193 10.879.134
2013-04-03 2013-04-01 4/A BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.598 52.107 -2,98 193,66 -309.469 10.091.042
2013-04-02 2013-04-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.598 52.107 -2,98 193,66 -309.469 10.091.042
2013-03-04 2013-03-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.598 53.705 -2,89 165,30 -264.149 8.877.436
2013-02-14 2013-02-13 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.598 55.303 -2,81 163,39 -261.097 9.035.957
2013-02-14 2013-02-12 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
A - Award 36.758 36.758
2013-02-12 2013-02-10 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -18.833 37.666 -33,33
2013-02-12 2013-02-10 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -8.890 56.901 -13,51 164,44 -1.461.872 9.356.800
2013-02-12 2013-02-10 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 18.833 65.791 40,11
2013-02-12 2013-02-09 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
J - Other -1.503 33.814 -4,26
2013-02-12 2013-02-09 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -9.767 35.317 -21,66
2013-02-12 2013-02-09 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -3.723 46.958 -7,35 164,44 -612.210 7.721.774
2013-02-12 2013-02-09 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 9.767 50.681 23,87
2013-01-24 2012-11-29 4 BIIB BIOGEN IDEC INC.
Common Stock
G - Gift 5.378 5.378
2013-01-24 2012-11-29 4 BIIB BIOGEN IDEC INC.
Common Stock
G - Gift -5.378 40.914 -11,62
2013-01-24 2012-11-29 4 BIIB BIOGEN IDEC INC.
Common Stock
G - Gift 5.378 5.378
2013-01-24 2012-11-29 4 BIIB BIOGEN IDEC INC.
Common Stock
G - Gift -5.378 46.292 -10,41
2012-11-02 2012-11-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -828 51.670 -1,58 139,73 -115.698 7.219.952
2012-11-02 2012-11-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -400 52.498 -0,76 138,64 -55.456 7.278.323
2012-11-02 2012-11-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.244 52.898 -2,30 139,46 -173.486 7.377.049
2012-10-02 2012-10-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -3.654 54.142 -6,32 149,16 -545.031 8.075.821
2012-09-05 2012-09-04 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -3.654 57.796 -5,95 145,90 -533.119 8.432.436
2012-08-02 2012-08-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -3.655 61.450 -5,61 146,30 -534.726 8.990.135
2012-07-18 2012-07-17 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.228 65.105 -1,85 146,04 -179.337 9.507.934
2012-07-18 2012-07-17 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.244 66.333 -1,84 146,04 -181.674 9.687.271
2012-07-17 2012-07-16 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -21.339 42.678 -33,33
2012-07-17 2012-07-16 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -8.780 67.577 -11,50 144,61 -1.269.676 9.772.310
2012-07-17 2012-07-16 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -8.899 76.357 -10,44 144,61 -1.286.884 11.041.986
2012-07-17 2012-07-16 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 21.339 85.256 33,39
2012-07-03 2012-07-02 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.183 63.917 -1,82 143,50 -169.760 9.172.090
2012-06-04 2012-06-01 4 BIIB BIOGEN IDEC INC.
Common Stock
S - Sale X -1.183 65.100 -1,78 128,63 -152.169 8.373.813
2012-05-25 2012-05-24 4 EXEL EXELIXIS INC
Option (right to buy)
A - Award 15.000 15.000
2012-02-22 2011-07-15 4/A BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -8.791 54.374 -13,92 104,00 -914.264 5.654.896
2012-02-13 2012-02-10 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
M - Exercise -18.833 56.499 -25,00
2012-02-13 2012-02-10 4 BIIB BIOGEN IDEC INC.
Common Stock
F - Taxes -7.007 66.283 -9,56 118,14 -827.807 7.830.674
2012-02-13 2012-02-10 4 BIIB BIOGEN IDEC INC.
Common Stock
M - Exercise 18.833 73.290 34,58
2012-02-10 2012-02-09 4 BIIB BIOGEN IDEC INC.
Restricted Stock Unit
A - Award 45.084 45.084
2010-07-19 3 BIIB BIOGEN IDEC INC.
Common Stock
0
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.256.915 -0,01 6,84 -684 8.597.299
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.257.015 -0,01 6,78 -678 8.522.562
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -200 1.257.115 -0,02 6,90 -1.380 8.674.094
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.257.315 -0,01 6,96 -696 8.750.912
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.257.415 -0,01 6,99 -699 8.789.331
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.257.515 -0,01 6,98 -698 8.777.455
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -200 1.257.615 -0,02 6,97 -1.394 8.765.577
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.257.815 -0,01 6,96 -696 8.754.392
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.257.915 -0,01 6,93 -693 8.717.351
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.258.015 -0,01 6,75 -675 8.491.601
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.258.115 -0,01 6,78 -678 8.530.020
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.258.215 -0,01 6,77 -677 8.518.116
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.258.315 -0,01 6,82 -682 8.581.708
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.258.415 -0,01 6,80 -680 8.557.222
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.258.515 -0,01 6,86 -686 8.633.413
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -200 1.258.615 -0,02 6,87 -1.374 8.646.685
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -300 1.258.815 -0,02 6,83 -2.049 8.597.706
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -106 1.259.115 -0,01 6,85 -726 8.624.938
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -100 1.259.221 -0,01 6,89 -689 8.676.033
2008-02-06 2008-02-06 4 EXEL EXELIXIS INC
Common Stock
S - Sale X -94 1.259.321 -0,01 6,85 -644 8.626.349
2005-12-14 2005-12-12 4 EXEL EXELIXIS INC
Option (right to buy)
A - Award 1.000.000 1.000.000
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)